Epidemiology of Escherichia coli, Klebsiella Species, and Proteus mirabilis strains producing extended-spectrum -βlactamases from clinical samples in the Kinki region of Japan

American Journal of Clinical Pathology

Volumn 137, Issue 4, 2012, Pages 620-626

  Nakamura, Tatsuya ^a,b   Komatsu, Masaru ^c   Yamasaki, Katsutoshi ^d   Fukuda, Saori ^e   Miyamoto, Yugo ^f   Higuchi, Takeshi ^g   Ono, Tamotsu ^h   Nishio, Hisaaki ⁱ   Sueyoshi, Noriyuki ^j   Kida, Kenji ^k   Satoh, Kaori ^l   Toda, Hirofumi ^l   Toyokawa, Masahiro ^m   Nishi, Isao ^m   Sakamoto, Masako ⁿ   Akagi, Masahiro ^o   Nakai, Isako ^p   Kofuku, Tomomi ^q   Orita, Tamaki ^r   Wada, Yasunao ^s   Zikimoto, Takuya ^t   Koike, Chihiro ^a   Kinoshita, Shohiro ^t   Hirai, Itaru ^b   Takahashi, Hakuo ^a   Matsuura, Nariaki ^b   Yamamoto, Yoshimasa ^b   more..

^a KANSAI MEDICAL UNIVERSITY HOSPITAL   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Bacteriological Testing Section of Central Laboratory   (Japan)

^d WAKAYAMA ROSAI HOSPITAL   (Japan)

^e TENRI HOSPITAL   (Japan)

^f National Hospital Organizaton Minami Wakayama Medical Center   (Japan)

^g KYOTO UNIVERSITY HOSPITAL   (Japan)

^h KYOTO SECOND RED CROSS HOSPITAL   (Japan)

ⁱ Shiga Medical Center for Adults   (Japan)

^j Social Insurance Shiga Hospital   (Japan)

^k OTSU RED CROSS HOSPITAL   (Japan)

^l KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^m OSAKA UNIVERSITY HOSPITAL   (Japan)

ⁿ The Research Foundation for Microbial Diseases of Osaka University   (Japan)

^o OSAKA POLICE HOSPITAL   (Japan)

^p SUMITOMO HOSPITAL   (Japan)

^q HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^r Takarazuka Municipal Hospital   (Japan)

^s HYOGO COLLEGE OF MEDICINE HOSPITAL   (Japan)

^t KOBE UNIVERSITY HOSPITAL   (Japan)

more..

Author keywords

Extended spectrum lactamases; Polymerase chain reaction; Replicon type; Surveillance

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE; BACTERIAL DNA; BETA LACTAMASE;

ARTICLE; BACTERIAL STRAIN; ESCHERICHIA COLI; GENOTYPE; JAPAN; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; BACTERIUM IDENTIFICATION; ESCHERICHIA COLI INFECTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; PROTEUS INFECTION;

BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; JAPAN; KLEBSIELLA; KLEBSIELLA INFECTIONS; MOLECULAR EPIDEMIOLOGY; PROTEUS INFECTIONS; PROTEUS MIRABILIS;

EID: 84860599792     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP48PDVKWQOXEZ     Document Type: Article

References (33)

1. Knothe H, Shah P, Krcmery V, et al.Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens . Infection. 1983;11:315-317. (Pubitemid 14213754)
2. Pitout JD, Hossain A, Hanson ND. Phenotypic and molecular detection of CTX-M-β-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol. 2004;42:5715-5721. (Pubitemid 39664358)
3. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933-951. (Pubitemid 32979636)
4. Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother. 2004;48:1-14. (Pubitemid 38040170)
5. Matsumoto Y, Ikeda F, Kamimura T, et al.Novel plasmid-mediated β-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins. Antimicrob Agents Chemother. 1988;32:1243-1246.
6. Doi Y, Adams J, O'Keefe A, et al.Community-acquired extended-spectrum β-lactamase producers, United States. Emerg Infect Dis. 2007;13:1121-1123. (Pubitemid 47048102)
7. Woodford N, Ward ME, Kaufmann ME, et al.Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother. 2004;54:735-743. (Pubitemid 39386725)
8. Ho PL, Poon WW, Loke SL, et al.Community emergence of CTX-M type extended-spectrum β-lactamases among urinary Escherichia coli from women. J Antimicrob Chemother. 2007;60:140-144. (Pubitemid 47073288)
9. Freeman JT, McBride SJ, Heffernan H, et al.Community-onset genitourinary tract infection due to CTX-M-15-producing Escherichia coli among travelers to the Indian subcontinent in New Zealand. Clin Infect Dis. 2008;47:689-692.
10. Hawkey PM. Prevalence and clonality of extended-spectrum β-lactamases in Asia. Clin Microbiol Infect. 2008;14:159-165. (Pubitemid 350269196)
11. Lewis JS Jr., Herrera M, Wickes B, et al.First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a US health care system. Antimicrob Agents Chemother. 2007;51:4015-4021. (Pubitemid 350057800)
12. Livermore DM, Canton R, Gniadkowski M, et al.CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother. 2007;59:165-174. (Pubitemid 47072053)
13. Mulvey MR, Bryce E, Boyd E, et al.Ambler class A extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp in Canadian hospitals. Antimicrob Agents Chemother. 2004;48:1204-1214. (Pubitemid 38405474)
14. Rossolini GM, D'Andrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum β-lactamases. Clin Microbiol Infect. 2008;14:33-41.
15. Villegas MV, Kattan JN, Quinteros MG, et al.Prevalence of extended-spectrum β-lactamases in South America. Clin Microbiol Infect. 2008;14:154-158. (Pubitemid 350269195)
16. Zong Z, Partridge SR, Thomas L, et al.Dominance of blaCTX-M within an Australian extended-spectrum β-lactamase gene pool. Antimicrob Agents Chemother. 2008;52:4198-4202.
17. Tzelepi E, Giakkoupi P, Sofianou D, et al.Detection of extended spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes . J Clin Microbiol. 2000;38:542-546. (Pubitemid 30082638)
18. Arlet G, Philippon A. Construction by polymerase chain reaction and use of intragenic DNA probes for three main types of transferable β-lactamases (TEM, SHV, CARB). FEMS Microbiol Lett. 1991;66:19-25.
19. Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8:159-166. (Pubitemid 351249250)
20. Carattoli A, Bertini A, Villa L, et al.Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63:219-228. (Pubitemid 41597366)
21. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2010. Document M100-S20.
22. Fang H, Ataker F, Hedin G, et al.Molecular epidemiology of extended-spectrum β-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J Clin Microbiol. 2008;46:707-712. (Pubitemid 351231321)
23. Yigit H, Queenan AM, Anderson GJ, et al.Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae . Antimicrob Agents Chemother. 2001;45:1151-1161. (Pubitemid 32230996)
24. Yong D, Toleman MA, Giske CG, et al.Characterization of a new metallo-β-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53:5046-5054.
25. Shibata N, Kurokawa H, Doi Y, et al.R classification of CTX-M-type β-lactamase genes identified in clinically isolated gram-negative bacilli in Japan. Antimicrob Agents Chemother. 2006;50:791-795. (Pubitemid 43191004)
26. Warren RE, Ensor VM, O'Neill P, et al.Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum β-lactamases in the UK. J Antimicrob Chemother. 2008;61:504-508. (Pubitemid 351321121)
27. Marcadé G, Deschamps C, Boyd A, et al.Replicon typing of plasmids in Escherichia coli producing extended-spectrum β-lactamases. J Antimicrob Chemother. 2009;63:67-71.
28. Elhani D, Bakir L, Aouni M, et al.Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia, 1999-2005. Clin Microbiol Infect. 2010;16:157-164.
29. Mena A, Plasencia V, García L, et al.Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J Clin Microbiol. 2006;4:2831-2837.
30. Nagano N, Shibata N, Saitou Y, et al.Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type β- lactamase. J Clin Microbiol. 2003;41:5530-5536.
31. Gruteke P, Goessens W, van Gils J, et al.Patterns of resistance associated with integrons, the extended-spectrum β-lactamase SHV-5 gene, and a multidrug efflux pump of Klebsiella pneumoniae causing a nosocomial outbreak. J Clin Microbiol. 2003;41:1161-1166. (Pubitemid 36307123)
32. Jones GL, Warren RE, Skidmore SJ, et al.Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum β-lactamases. J Antimicrob Chemother. 2008;62:1245-1251.
33. Gilbert DN, Moellering RC, Eliopoulos GM, et al.The Sanford Guide to Antimicrobial Therapy 2011 . 41st ed. Hyde Park, VT: Antimicrobial Therapy; 2011.